CN107789022B - Chain type quick hemostasis device - Google Patents
Chain type quick hemostasis device Download PDFInfo
- Publication number
- CN107789022B CN107789022B CN201610825129.5A CN201610825129A CN107789022B CN 107789022 B CN107789022 B CN 107789022B CN 201610825129 A CN201610825129 A CN 201610825129A CN 107789022 B CN107789022 B CN 107789022B
- Authority
- CN
- China
- Prior art keywords
- hemostatic
- units
- hemostasis
- chain
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000023597 hemostasis Effects 0.000 title claims abstract description 50
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 129
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 61
- 206010052428 Wound Diseases 0.000 claims abstract description 58
- 239000002775 capsule Substances 0.000 claims description 40
- 238000004043 dyeing Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 8
- 229940124599 anti-inflammatory drug Drugs 0.000 claims description 6
- 239000002198 insoluble material Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 2
- 210000004013 groin Anatomy 0.000 abstract description 6
- 230000000740 bleeding effect Effects 0.000 description 7
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 238000001804 debridement Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000037906 ischaemic injury Diseases 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 208000023329 Gun shot wound Diseases 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B2017/12004—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for haemostasis, for prevention of bleeding
Abstract
The invention relates to the field of medical equipment, in particular to a chain type rapid hemostasis device. The present invention comprises a plurality of hemostatic units for hemostasis of a wound; the hemostatic units are connected in series to form a hemostatic chain through connecting lines arranged among the hemostatic units. The invention is particularly suitable for the rapid hemostasis of bullet wounds in the groin or axillary area.
Description
Technical Field
The invention relates to the field of medical equipment, in particular to a chain type rapid hemostasis device.
Background
The problem of blood loss is still the most urgent problem to be solved in the current war wound treatment, and according to related data, a large number of cases which can not be controlled account for 90% of death cases.
At present, the tourniquet used in battlefield has the defects of incomplete hemostasis, inconvenient operation, incapability of using by one hand, difficult control and observation of pressure and the like, and is easy to cause serious pain or tissue damage. After the tourniquet which is currently arranged in an army is used, the tissue at the far end is easy to be damaged by ischemia, so that the tissue necrosis is caused, and the amputation and even the life are threatened due to the anaerobic infection. The use of tourniquets on the battlefield is discouraged due to the fear of causing limb necrosis.
From the above, it can be seen that the control of blood loss at the junction of trunk and limbs on the battlefield is still the focus of current research, especially when major arteriovenous trauma in the groin area or armpit is ruptured, and the means that can be taken on the battlefield is extremely limited.
Often the wound surface of a gunshot wound is irregular, especially the wound surface caused by a rifle. If gunshot injuries at the groin area or the armpit are combined with main arteriovenous rupture bleeding, the existing method of ensuring local pressurization or binding and hemostasis by using a tourniquet cannot achieve ideal hemostasis effect.
Disclosure of Invention
The invention aims to: provides a chain type rapid hemostasis device suitable for rapid hemostasis of war wounds, in particular to rapid hemostasis of bullet wounds in groin or armpit areas.
The invention is realized by the following technical scheme: the utility model provides a quick hemostasis device of chain which characterized in that: it comprises a plurality of hemostatic units for hemostasis of wounds; the hemostatic units are connected in series to form a hemostatic chain through connecting lines arranged among the hemostatic units.
The invention is particularly suitable for war injury first aid because of the characteristics of convenient carrying, specially suitable for hemostasis of bullet wounds and the like, highlights the specificity of battlefield first aid objects and application purposes, and is more suitable for the needs of war service support; not only can achieve the hemostasis effect of the traditional means, but also can reduce the complication incidence rate of the tourniquet, can properly prolong the application time of the hemostasis device, strives for longer sending-back time so as to be convenient for graded treatment.
The working principle and the process are as follows:
when in use, the hemostatic chain is only needed to be quickly filled into a wound, and then the surface of the wound is properly blocked and fixed, for example, the bandage is simply bound, the surface of the wound is pasted by a medical adhesive tape, and the like, so that the hemostatic chain is simple and efficient.
For better implementation of the scheme, the following optimization scheme is also provided:
further, part of the hemostasis unit is composed of a hemostasis block which is expanded by absorbing water, and part of the hemostasis unit is composed of a functional capsule body used for assisting hemostasis.
Further, to further increase the effectiveness of the hemostatic chain:
the functional capsule body is one or any combination of a decompression capsule body filled with gas, a dyeing capsule body filled with dye and an anti-inflammatory capsule body filled with anti-inflammatory drugs.
The pressure reducing bag body is used for adjusting the compression force of the wound and making a certain space for the expansion of the hemostatic mass, so as to prevent the tissue around the wound from being torn due to the over expansion of the hemostatic mass.
The dyeing capsule body is used for dyeing necrotic tissues near the wound so as to debride the necrotic tissues of the wound at a later stage, and the dye is usually methylene blue;
the anti-inflammatory sac body has the function of resisting infection of tissues near a wound and preventing the wound from being infected.
In addition, the number of the blood stopping clots is 50-80 per hundred of the hemostasis units, the number of the pressure reducing capsules is 5-10, the number of the dyeing capsules is 5-10, and the number of the anti-inflammatory capsules is 10-20, wherein each blood stopping clot and each functional capsule can be connected in series randomly or in a regular arrangement.
Further, in order to make each functional capsule easier to be broken:
the outer surface of the functional capsule body is provided with a thin-wall area.
The wall thickness of the thin-wall area is different from that of the functional balloon in other areas, so that a stress concentration area is formed in the thin-wall area, and the thin-wall area is easier to crush when the hemostatic block expands to press the functional balloon.
Further, the hemostatic chain is conveniently taken out from the wound in the later debridement process without damaging tissues nearby the wound:
the hemostasis units are arranged in a wave shape and distributed at wave crests or wave troughs;
the connecting line is made of insoluble materials, and soluble connecting lines are respectively connected between every two adjacent odd hemostatic units and every two adjacent even hemostatic units counted from the first hemostatic unit at the starting end.
The scheme is specially designed for wounds caused by the process that bullets enter the body when warriors in the battlefield, as the wounds at the bullet inlet ends are usually through wounds and the wound surfaces are mostly irregular, the hemostatic chains are randomly stacked in the wound surfaces, and if the hemostatic units are not uniformly distributed, the wounds are easily blocked, so that the hemostatic chains are not easily taken out during later debridement; after the hemostatic units are arranged in a wavy manner in advance, the hemostatic units can be uniformly arranged in the wound surface of the irregular through wound without blocking the wound, so that the hemostatic chain is taken out of the wound greatly and conveniently.
Meanwhile, the purpose of the soluble wiring is to enable the hemostatic units to be always in wavy arrangement before use, and after the hemostatic chain is placed in a wound, the soluble wiring is melted by blood, so that the hemostatic units are connected in series to form the wiring when the hemostatic chain is removed in the later debridement, and the hemostatic chain can be conveniently pulled out from the wound.
Further, in order to fill the hemostatic chain to the big wound rapidly and to take out the hemostatic chain from the wound and not damage the wound in the later stage: the hemostatic chain is wrapped by a soluble bag body.
The scheme is specially designed according to different wound surface characteristics caused by bullets to local tissues, and because the wound at the bullet shooting end usually has an explosive large wound, the wound area is large and bleeding is serious;
in the face of such bleeding situation, in order to reach the purpose of stanching rapidly in the battlefield in the very first time, every soluble bag body is inside all to be filled with the hemostatic chain of the same unit to make the quick hemostasis bag of standard with every bag body, therefore adopt quick hemostasis bag to fill rapidly to this kind of wound on the battlefield, thereby block up the wound in the very first time and have reached good hemostatic effect.
Further, to achieve more convenient filling of the hemostatic chain into the wound: the hemostatic units are in a bullet shape after being spliced.
Compared with the prior art, the invention has the beneficial effects that:
1. the invention adopts the connecting lines to connect the hemostatic units in series to form the hemostatic chain, thereby greatly facilitating the taking out of all the hemostatic units from the wound in the later debridement work and avoiding the single hemostatic unit from remaining in the wound;
2. the invention can rapidly and effectively block wounds caused by being hit by various firearms, is flexible, convenient and easy to fix, is not limited by physiological structures, can rapidly stop bleeding particularly at arteriovenous bleeding positions in groin areas, and can not cause ischemic injury of distal tissues;
3. the invention is especially suitable for war injury first aid, highlights the specificity of battlefield first aid objects and application purposes, and is more suitable for the needs of war medical service support; the hemostatic effect of the traditional means can be achieved, the complication incidence rate of the tourniquet in use can be reduced, the application time of the hemostatic device can be properly prolonged, and longer sending time is strived for so as to be convenient for graded treatment;
4. the wound surface is filled by using the invention, the wound surface of the bullet can be quickly and fully filled, so that the arteriovenous bleeding part in the groin area can be quickly stopped bleeding, and the ischemic injury of the far-end tissue can not be caused.
Drawings
FIG. 1 is a schematic view of example 1;
FIG. 2 is a schematic view of example 6;
FIG. 3 is a schematic view of the functional bladder of FIG. 2;
FIG. 4 is a schematic view of example 7;
FIG. 5 is a schematic view of example 8;
FIG. 6 is a schematic view of example 9.
Description of reference numerals: 1-hemostasis unit, 11-hemostasis fast, 12-functional capsule, 121-decompression capsule, 122-dyeing capsule, 123-anti-inflammatory capsule, 124-thin wall area, 2-connecting line, 3-soluble connecting line and 4-soluble bag body.
Detailed Description
The invention is described in detail below with reference to the following description of the drawings:
example 1:
as shown in fig. 1, the present embodiment includes a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Example 2:
the present embodiment comprises a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Further, a part of the hemostatic unit is formed by the hemostatic block 11 expanding by absorbing water, and a part of the hemostatic unit is formed by the functional capsule 12 for assisting hemostasis, and the functional capsule 12 is a pressure reducing capsule 121 filled with gas.
Further, a thin-wall region 124 is provided on the outer surface of the functional capsule 12.
Example 3:
the present embodiment comprises a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Further, a part of the hemostatic unit is formed by the hemostatic block 11 expanding by absorbing water, and a part of the hemostatic unit is formed by the functional balloon 12 for assisting hemostasis, and the functional balloon 12 is a dyeing balloon 122 filled with dye.
Example 4:
the present embodiment comprises a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Further, a part of the hemostatic unit is formed by the hemostatic block 11 expanding by absorbing water, a part of the hemostatic unit is formed by the functional capsule 12 for assisting hemostasis, and the anti-inflammatory capsule 123 filled with anti-inflammatory drugs is arranged inside.
Example 5:
the present embodiment comprises a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Further, a part of the hemostatic unit is composed of the hemostatic block 11 expanding by absorbing water, and a part of the hemostatic unit is composed of the functional balloon 12 for assisting hemostasis, and the functional balloon 12 is a pressure reducing balloon 121 filled with gas inside and a dyeing balloon 122 filled with dye inside.
Example 6:
as shown in fig. 2-3, the present embodiment includes a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Further, a part of the hemostatic unit is composed of the hemostatic mass 11 expanding by absorbing water, and a part of the hemostatic unit is composed of the functional balloon 12 for assisting hemostasis, and the functional balloon 12 is a pressure reducing balloon 121 filled with gas inside, a dyeing balloon 122 filled with dye inside, and an anti-inflammatory balloon 123 filled with anti-inflammatory drug inside.
Example 7:
as shown in fig. 4, the present embodiment includes a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Further, the hemostatic units 1 are arranged in a wavy manner, and the hemostatic units 1 are distributed at wave crests or wave troughs;
the connecting line 2 is made of insoluble materials, and soluble connecting lines 3 are respectively connected between every two adjacent odd-numbered hemostatic units 1 and between every two adjacent even-numbered hemostatic units 1 from the first hemostatic unit 1 at the starting end.
Example 8:
as shown in fig. 5, the present embodiment includes a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Further, part of the hemostatic unit is composed of a hemostatic block 11 which swells by absorbing water, and part of the hemostatic unit is composed of a functional capsule 12 for assisting hemostasis.
Further, the functional capsule 12 is one or any combination of a pressure-reducing capsule 121 filled with gas, a dyeing capsule 122 filled with dye, and an anti-inflammatory capsule 123 filled with anti-inflammatory drug.
Further, a thin-wall region 124 is provided on the outer surface of the functional capsule 12.
Further, the hemostatic units 1 are arranged in a wavy manner, and the hemostatic units 1 are distributed at wave crests or wave troughs;
the connecting line 2 is made of insoluble materials, and soluble connecting lines 3 are respectively connected between every two adjacent odd-numbered hemostatic units 1 and between every two adjacent even-numbered hemostatic units 1 from the first hemostatic unit 1 at the starting end.
Further, the hemostatic units 1 are in a bullet shape after being spliced.
Example 9:
as shown in fig. 6, the present embodiment includes a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Furthermore, a soluble bag body 4 is wrapped outside the hemostatic chain.
Example 10:
the present embodiment comprises a plurality of hemostatic units 1 for hemostasis of wounds; the hemostatic units 1 are connected in series to form a hemostatic chain through connecting lines 2 arranged among the hemostatic units 1.
Further, part of the hemostatic unit is composed of a hemostatic block 11 which swells by absorbing water, and part of the hemostatic unit is composed of a functional capsule 12 for assisting hemostasis.
Further, the functional capsule 12 is one or any combination of a pressure-reducing capsule 121 filled with gas, a dyeing capsule 122 filled with dye, and an anti-inflammatory capsule 123 filled with anti-inflammatory drug.
Further, a thin-wall region 124 is provided on the outer surface of the functional capsule 12.
While the invention has been illustrated and described with respect to specific embodiments and alternatives thereof, it will be understood that various changes and modifications can be made without departing from the spirit and scope of the invention. It is understood, therefore, that the invention is not to be in any way limited except by the appended claims and their equivalents.
Claims (6)
1. The utility model provides a quick hemostasis device of chain which characterized in that: it comprises a plurality of hemostatic units (1) for hemostasis of wounds; the hemostatic units (1) are connected in series to form a hemostatic chain through connecting lines (2) arranged among the hemostatic units (1);
the hemostasis units (1) are arranged in a wave shape, and the hemostasis units (1) are distributed at wave crests or wave troughs;
the connecting lines (2) are made of insoluble materials, and soluble connecting lines (3) are respectively connected between every two adjacent odd-numbered hemostatic units (1) and between every two adjacent even-numbered hemostatic units (1) from the first hemostatic unit (1) at the starting end.
2. The chained rapid hemostatic device of claim 1, wherein: the hemostatic chain is wrapped by a soluble bag body (4).
3. The chained rapid hemostatic device of any one of claims 1-2, wherein: part of the hemostasis unit is composed of a hemostasis block (11) which is expanded by absorbing water, and part of the hemostasis unit is composed of a functional capsule (12) for assisting hemostasis.
4. The chained rapid hemostatic device of claim 3, wherein: the functional capsule body (12) is one or any combination of a decompression capsule body (121) filled with gas, a dyeing capsule body (122) filled with dye and an anti-inflammatory capsule body (123) filled with anti-inflammatory drugs.
5. The chained rapid hemostatic device of claim 3, wherein: the outer surface of the functional capsule body (12) is provided with a thin-wall area (124).
6. The chained rapid hemostatic device of any one of claims 1-2, wherein: the hemostatic units (1) are spliced to form a bullet shape.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610825129.5A CN107789022B (en) | 2016-08-31 | 2016-08-31 | Chain type quick hemostasis device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610825129.5A CN107789022B (en) | 2016-08-31 | 2016-08-31 | Chain type quick hemostasis device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107789022A CN107789022A (en) | 2018-03-13 |
| CN107789022B true CN107789022B (en) | 2019-12-20 |
Family
ID=61529623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610825129.5A Active CN107789022B (en) | 2016-08-31 | 2016-08-31 | Chain type quick hemostasis device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107789022B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019095391A1 (en) * | 2017-11-20 | 2019-05-23 | 王洛 | Chain-type quick hemostasis device |
| CN109091189B (en) * | 2018-09-03 | 2020-11-20 | 中国空间技术研究院 | Self-adaptive mesh hemostasis structure, device and method |
| CN109009307B (en) * | 2018-09-03 | 2020-11-20 | 中国空间技术研究院 | Circular-arc elastic plate hemostasis structure, device and method |
| CN109091188B (en) * | 2018-09-03 | 2020-11-20 | 中国空间技术研究院 | Foldable staggered elastic plate hemostasis structure with inhaul cable, hemostasis device and hemostasis method |
| CN112451033A (en) * | 2020-12-07 | 2021-03-09 | 中国人民解放军陆军特色医学中心 | Groin hemostasis device |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN202437233U (en) * | 2012-01-20 | 2012-09-19 | 鲍诗平 | Hemostatic device provided with air bag and used for front and rear nostrils of nasal cavity |
| EP3258974A1 (en) * | 2015-02-16 | 2017-12-27 | Manoryk, Petro Andriyovych | Hemostatic composition and hemostatic device (variants) |
| CN206880705U (en) * | 2016-08-31 | 2018-01-16 | 王洛 | Chain type fast hemostasis device |
-
2016
- 2016-08-31 CN CN201610825129.5A patent/CN107789022B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107789022A (en) | 2018-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107789022B (en) | Chain type quick hemostasis device | |
| CN107252335B (en) | Hemostasis device and injector for pushing hemostasis device | |
| CN206880705U (en) | Chain type fast hemostasis device | |
| CN208524948U (en) | Stop blooding syringe | |
| CN109091189B (en) | Self-adaptive mesh hemostasis structure, device and method | |
| CN108030529B (en) | Rapid hemostasis device with air bag | |
| CN108294798B (en) | Rapid hemostasis device with guide wire | |
| CN108294797B (en) | The manufacturing method of fast hemostasis device | |
| WO2019095391A1 (en) | Chain-type quick hemostasis device | |
| CN207996223U (en) | Hemostasis device and syringe for pushing the hemostasis device | |
| CN111248965A (en) | Uterine cavity compression type hemostasis device for obstetrical department | |
| CN109009307B (en) | Circular-arc elastic plate hemostasis structure, device and method | |
| CN207654190U (en) | A kind of injectable styptic sponge device, syringe and external member | |
| CN205924674U (en) | Device fast stanchs | |
| CN109044453B (en) | Gasbag and elastic plate mixed hemostasis structure and hemostasis device | |
| CN113017752A (en) | Pull formula hemostasis structure based on abnormal shape elasticity wind spring | |
| CN109044452B (en) | Gasbag and alternating expression elastic plate mix hemostasis structure and hemostasis device | |
| CN109044460B (en) | Foldable mixed hemostasis structure based on spiral spring and hemostasis device | |
| CN109044450B (en) | Cut formula hinge hemostasis structure and hemostasis device | |
| CN204814038U (en) | A arteria femoralis hemostasis device for promptly help in battlefield | |
| CN205924682U (en) | Cartridge hemostasis device | |
| CN210056133U (en) | Emergency binding hemostasis device | |
| CN109091190A (en) | A kind of alternating expression elastic plate hemostatic structures with drag-line and hemostasis device and method | |
| CN109044447B (en) | Through-line type horizontal scissor hinge hemostasis structure and injection type horizontal scissor hinge hemostasis device | |
| CN109044455B (en) | Horizontal shear type hinge mixed hemostasis structure and injection type mixed hemostasis device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231018 Address after: 350001 No.156, West 2nd Ring North Road, Fuzhou City, Fujian Province Patentee after: The 900th Hospital of the Joint Logistics Support Force of the Chinese PLA Address before: No. 202, Building 6, Heyang Building, Hexia Street, Wuhang Town, Changle City, Fujian Province, 350200 Patentee before: Wang Luo Patentee before: Yang Weijin Patentee before: Wang Yu |
|
| TR01 | Transfer of patent right |